Amarin Corp Plcuk (AMRN) Inventory (2012 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Inventory of $164.1 million for Q2 2026, down 4.17% year-over-year from $171.2 million in Q2 2025, and down 10.62% quarter-over-quarter from $183.6 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Inventory (2012 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Inventory for 15 consecutive years, with $164.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory fell 4.17% year-over-year to $164.1 million; the TTM figure through Jun 2026 stood at $164.1 million (down 4.17% YoY), while the FY2025 annual figure was $195.9 million, up 17.98% from the prior year.
- Inventory eased to $164.1 million in Q2 2026 per AMRN's latest filing, from $183.6 million in the prior quarter.
- Across five years, Inventory topped out at $267.8 million in Q1 2022 and bottomed at $159.5 million in Q1 2025.
- Historically, Inventory has averaged $214.4 million across 5 years, with a median of $225.8 million in 2022.
- On a YoY basis, Inventory climbed as much as 17.98% in 2025 and fell as far as 37.52% in 2025.
- Amarin Corp Plc\Uk's Inventory stood at $228.7 million in 2022, then gained by 13.07% to $258.6 million in 2023, then slumped by 35.79% to $166.0 million in 2024, then advanced by 17.98% to $195.9 million in 2025, then slipped by 16.24% to $164.1 million in 2026.
- Business Quant data shows AMRN's Inventory at $164.1 million in Q2 2026, $183.6 million in Q1 2026, and $195.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.51 Bn | 632.75 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 470.18 Bn | 463.61 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 376.85 Bn | 369.71 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 303.27 Bn | 295.58 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 257.42 Bn | 252.52 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 182.16 Bn | 178.98 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 159.30 Bn | 147.60 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 106.12 Bn | 101.95 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Amarin Corp Plcuk | 5.87 Bn | 5.56 Bn | 14.99 Mn | 164.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 164.10 Mn |
| Mar 31, 2026 | 183.60 Mn |
| Dec 31, 2025 | 195.91 Mn |
| Sep 30, 2025 | 184.70 Mn |
| Jun 30, 2025 | 171.24 Mn |
| Mar 31, 2025 | 159.50 Mn |
| Dec 31, 2024 | 166.05 Mn |
| Sep 30, 2024 | 224.00 Mn |
| Jun 30, 2024 | 239.41 Mn |
| Mar 31, 2024 | 255.30 Mn |
| Dec 31, 2023 | 258.62 Mn |
| Sep 30, 2023 | 254.50 Mn |
| Jun 30, 2023 | 227.02 Mn |
| Mar 31, 2023 | 225.81 Mn |
| Dec 31, 2022 | 228.73 Mn |
| Sep 30, 2022 | 227.61 Mn |
| Jun 30, 2022 | 225.80 Mn |
| Mar 31, 2022 | 267.82 Mn |
| Dec 31, 2021 | 234.68 Mn |
| Sep 30, 2021 | 309.30 Mn |